Intuitive Surgical, Inc. $ISRG Stock Holdings Increased by Capital Asset Advisory Services LLC

Capital Asset Advisory Services LLC raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.6% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,259 shares of the medical equipment provider’s stock after acquiring an additional 452 shares during the period. Capital Asset Advisory Services LLC’s holdings in Intuitive Surgical were worth $3,906,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the business. Whitaker Myers Wealth Managers LTD. bought a new stake in Intuitive Surgical during the 2nd quarter valued at $620,000. M & L Capital Management Ltd raised its stake in Intuitive Surgical by 0.3% during the 2nd quarter. M & L Capital Management Ltd now owns 17,750 shares of the medical equipment provider’s stock valued at $9,646,000 after acquiring an additional 50 shares in the last quarter. Abner Herrman & Brock LLC raised its stake in Intuitive Surgical by 152.1% during the 2nd quarter. Abner Herrman & Brock LLC now owns 31,490 shares of the medical equipment provider’s stock valued at $17,112,000 after acquiring an additional 19,000 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. raised its stake in Intuitive Surgical by 22.6% during the 2nd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 2,810 shares of the medical equipment provider’s stock valued at $1,527,000 after acquiring an additional 518 shares in the last quarter. Finally, Arvest Investments Inc. bought a new stake in Intuitive Surgical during the 2nd quarter valued at $297,000. Institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In related news, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the transaction, the insider owned 19,827 shares in the company, valued at $9,368,059.23. This trade represents a 59.69% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares in the company, valued at $173,845.44. This represents a 92.73% decrease in their position. The disclosure for this sale can be found here. Insiders sold 45,224 shares of company stock worth $21,716,492 in the last quarter. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Stock Down 1.4%

NASDAQ:ISRG opened at $449.68 on Friday. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The firm has a market capitalization of $161.20 billion, a price-to-earnings ratio of 62.72, a price-to-earnings-growth ratio of 4.78 and a beta of 1.61. The stock has a fifty day simple moving average of $485.67 and a 200 day simple moving average of $508.21.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The business had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. During the same quarter last year, the company posted $1.78 EPS. Intuitive Surgical’s revenue for the quarter was up 21.4% on a year-over-year basis. Equities analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Upgrades and Downgrades

ISRG has been the subject of several research analyst reports. Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Truist Financial upped their price target on shares of Intuitive Surgical from $590.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, July 23rd. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $615.00 price objective on shares of Intuitive Surgical in a research note on Tuesday, August 19th. Piper Sandler reiterated an “overweight” rating and issued a $595.00 target price (up from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Finally, Citigroup restated a “buy” rating and set a $650.00 target price (up from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Thirteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $595.95.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.